Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faecal Microbiota Transplantation for Prevention of Graft-versus-host Sisease After Allogeneic Stem Cell Transplantation for Haematological Malignancies

NCT04935684 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT04935684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faecal Microbiota Transplantation for Prevention of Graft-versus-host Sisease After Allogeneic Stem Cell Transplantation for Haematological Malignancies
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Phase 2
Overall status
Recruiting
Start date
December 20, 2022
Completion date
May 31, 2030
Enrollment
150 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia in remission, chronic lymphocytic leukemia, hodgkin lymphoma, lymphoma, non-hodgkin, myelodysplastic syndromes, myeloma, myeloproliferative syndrome